NCT00514657View on ClinicalTrials.gov

Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2

PHASE2CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

December 31, 2001

Study Completion Date

February 29, 2004

Conditions
Periodontitis
Interventions
DRUG

Trafermin (genetical recombinant of human basic Fibroblast Growth Factor)

Sponsors
All Listed Sponsors
lead

Kaken Pharmaceutical

INDUSTRY